Citadel Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,900
Closed -$9.04K 16041
2024
Q4
$9.04K Buy
16,900
+4,100
+32% +$2.86K ﹤0.01% 13660
2024
Q3
$22.5K Buy
12,800
+4,800
+60% +$6.7K ﹤0.01% 12694
2024
Q2
$9.36K Sell
8,000
-176,600
-96% -$442K ﹤0.01% 13141
2024
Q1
$1.67M Buy
184,600
+168,800
+1,068% +$1.64M ﹤0.01% 5881
2023
Q4
$172K Sell
15,800
-38,000
-71% -$285K ﹤0.01% 10183
2023
Q3
$433K Buy
53,800
+25,700
+91% +$214K ﹤0.01% 8385
2023
Q2
$305K Sell
28,100
-1,500
-5% -$12.8K ﹤0.01% 9013
2023
Q1
$204K Sell
29,600
-25,525
-46% -$160K ﹤0.01% 10151
2022
Q4
$219K Buy
55,125
+13,700
+33% +$67.3K ﹤0.01% 9954
2022
Q3
$275K Sell
41,425
-4,200
-9% -$25.9K ﹤0.01% 9759
2022
Q2
$221K Buy
45,625
+3,800
+9% +$23.1K ﹤0.01% 10488
2022
Q1
$391K Sell
41,825
-68,950
-62% -$685K ﹤0.01% 9965
2021
Q4
$1.32M Sell
110,775
-48,400
-30% -$559K ﹤0.01% 7224
2021
Q3
$1.81M Buy
159,175
+12,975
+9% +$178K ﹤0.01% 6617
2021
Q2
$2.62M Sell
146,200
-41,000
-22% -$660K ﹤0.01% 5922
2021
Q1
$2.9M Buy
187,200
+10,975
+6% +$159K ﹤0.01% 5529
2020
Q4
$2.15M Buy
+176,225
New +$2.46M ﹤0.01% 5208
2020
Q3
Sell
-6,175
Closed -$63K 10917
2020
Q2
$63K Sell
6,175
-1,150
-16% -$10.6K ﹤0.01% 9205
2020
Q1
$59K Buy
7,325
+225
+3% +$1.95K ﹤0.01% 8954
2019
Q4
$61K Sell
7,100
-1,350
-16% -$7.58K ﹤0.01% 8699
2019
Q3
$52K Sell
8,450
-4,600
-35% -$37.2K ﹤0.01% 8692
2019
Q2
$217K Sell
13,050
-1,775
-12% -$30.8K ﹤0.01% 8076
2019
Q1
$248K Sell
14,825
-33,525
-69% -$483K ﹤0.01% 7893
2018
Q4
$555K Buy
48,350
+39,525
+448% +$800K ﹤0.01% 6243
2018
Q3
$353K Buy
8,825
+375
+4% +$10.7K ﹤0.01% 7315
2018
Q2
$239K Buy
8,450
+1,975
+31% +$43.8K ﹤0.01% 7599
2018
Q1
$99K Buy
+6,475
New +$154K ﹤0.01% 7715